Covered recipient · General Payments record
TYLER FRANCIS STEWART
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$20,202.06
- Reported across 53 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Honoraria | $2,739.00 | 1 |
| Consulting Fee | $555.00 | 1 |
| Food and Beverage | $515.20 | 11 |
| Education | $18.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $3,055.60 | 4 |
| Acerta Pharma LLC | $612.43 | 4 |
| Merck Sharp & Dohme Corporation | $55.09 | 2 |
| Ferring Pharmaceuticals Inc. | $43.16 | 1 |
| EISAI INC. | $39.75 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $21.17 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $555.00 | 02/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105370062 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.10 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104612134 | CMS |
| AstraZeneca Pharmaceuticals LP | $29.21 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104612144 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.12 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105266288 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $21.17 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086132262 | CMS |
| Eisai Inc. | $20.41 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110786497 | CMS |
| Eisai Inc. | $19.34 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110786499 | CMS |
| Ferring Pharmaceuticals Inc. | $43.16 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137513300 | CMS |
| Merck Sharp & Dohme LLC | $31.54 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141629243 | CMS |
| Merck Sharp & Dohme LLC | $23.55 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141846093 | CMS |
| PFIZER INC. | $163.60 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131472695 | CMS |
| PFIZER INC. | $2,739.00 | 02/26/2024 | Honoraria | Undisputed | 01/23/2026 | 1131472699 | CMS |
| PFIZER INC. | $18.00 | 02/27/2024 | Education | Undisputed | 01/23/2026 | 1131590973 | CMS |
| PFIZER INC. | $135.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131482540 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.